logo
BMW iX3 prototype drive: your next-gen EV is nearly here

BMW iX3 prototype drive: your next-gen EV is nearly here

The Verge11-06-2025
There's a fight for control going on inside the cockpits of many modern cars. Enable all the active safety systems in a Tesla, and it'll do most of the steering for you. But if it makes an errant turn or meanders a little too far this way or that in the lane (and trust me, it will), you're left wrestling the wheel out of Autopilot's virtual hands.
Assistance systems from other manufacturers do better at ceding control whenever you feel like taking over, but BMW is about to take that to a new level with the first car built on its upcoming Neue Klasse platform. It includes an advanced driver assist system that the company says is a proper symbiosis, where the car's sensors and systems don't fight with or yell at you but instead work with you to make driving safer and less stressful.
I sampled this suite in a prototype of BMW's iX3, the first electric SUV on the Neue Klasse platform, designed from the ground up to offer more range, better handling, and way more smarts. BMW is promising 400 miles of range from a new battery architecture that can charge at up to 400 kW. That means adding something like 200 miles of range in 10 minutes, but there's a lot more to it than that.
Better brains
At the core of the iX3's safety system is a computing platform that BMW calls a 'superbrain.' That's an evocative term for a Qualcomm Snapdragon Ride chip, but it does offer far more power than anything the company has put on the road before. That's paired with a more advanced sensor suite, with better cameras and higher-fidelity radar sensors, all combined to give a better view of the world around.
One of those key sensors is the driver monitoring suite, which can detect where you're looking and whether you're paying attention while behind the wheel. Plenty of cars offer some degree of monitoring like this, usually nagging you with beeping and blinking unpleasantries when your eyes linger on a roadside distraction for too long. The iX3 goes beyond that by using eye-tracking technology to not just complain, but actually improve your experience.
If you're driving down the highway and BMW's highway assistant is active, it'll steer itself and even change lanes. In some current BMWs, you can just look in the mirror to initiate a lane change. The iX3 takes that a step further by proactively putting on the turn signal for you should you take the wheel and change lanes yourself.
Yes, finally, a BMW designed to tackle the most common preconception about BMW drivers: they never signal before changing lanes.
Try to change lanes manually without checking the blind spot, the lane-keep assistance system will resist the change and try to keep you where you are. But, if you've looked first, the car won't resist your control at all, as you've proved to it that you're doing your part.
The car will detect your attention in other ways, too. I had a chance to drive next to a dummy pedestrian standing partially in my lane. Without any input from me, the car came smoothly to a stop. But, when I tried again, steering slightly to the left and showing that I was paying attention, the car allowed me to move out of the lane without resistance.
Smooth driving, smoother stopping
I also got a chance to sample the other brain inside the new iX3, which the company has unfortunately labeled 'Heart of Joy.' This in-house developed processor aggregates all the traction, stability, and electric motor management functions that are typically handled by a dozen different processors sourced from a dozen different suppliers and scattered throughout the car.
Unifying all that has some significant implications. The car can more quickly and seamlessly manage power to the dual motors that give it 400 horsepower and all-wheel drive, so when I was sliding the camouflaged prototype around a wet test track, it felt like the stability and traction control systems were working to help me, rather than just trying desperately to slow me down.
But when it was time to pause the action, something almost magical happened. On a test track, I was told to close my eyes and let the iX3 bring itself to a stop. That process of deceleration was so smooth that I genuinely couldn't tell when the wheels had stopped rolling. The new systems controlling those electric motors allow more precise application of the regenerative braking function. That not only means smoother one-pedal driving, but the kind of perfectly controlled stop that'll keep your passengers from getting jostled at every red light.
An irresistible EV?
Ultra-smooth stopping is a small thing, but it really does increase the comfort of driving around in the iX3. By the end of the day, I was blown away by everything BMW's new EV brings to the table. And that's on top of the big, dashboard-spanning Panoramic Vision display, which runs from one pillar to another to provide a customizable and interactive information display.
The big question, though, is whether any of this will be enough to convince the largely EV-skeptical luxury car buyers out there that all this is good enough to finally make the switch away from internal combustion. The company's gas-powered X3 is consistently one of its top sellers, and while that isn't going away, BMW clearly has high hopes that the iX3 will bring that kind of sales success to its battery-powered efforts.
But it's just the first of multiple models planned on this Neue Klasse platform, all with the same combination of tech and finesse. If they're successful, maybe the world can finally put that BMW blinker stigma to bed for good.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Is CRISPR Therapeutics' (CRSP) Rising Net Loss a Sign of Bold Investment or Growing Pressure?
Is CRISPR Therapeutics' (CRSP) Rising Net Loss a Sign of Bold Investment or Growing Pressure?

Yahoo

time18 minutes ago

  • Yahoo

Is CRISPR Therapeutics' (CRSP) Rising Net Loss a Sign of Bold Investment or Growing Pressure?

CRISPR Therapeutics AG recently reported its second quarter 2025 earnings, posting revenue of US$892,000, up from US$517,000 a year ago, but recording a net loss of US$208.55 million, up from US$126.41 million in the same period last year. Despite modest revenue gains, the significantly wider loss per share suggests rising costs or investment pressures are impacting the company's financial trajectory. We'll explore how the widening net loss and higher reported expenses could reshape CRISPR Therapeutics' investment narrative going forward. The end of cancer? These 26 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's. What Is CRISPR Therapeutics' Investment Narrative? To be a shareholder in CRISPR Therapeutics, you need conviction in the promise of gene-editing breakthroughs and the company's ability to translate pipeline progress into eventual commercial returns. The latest earnings report, though, spotlights a widening net loss and sharply higher operating expenses. While ongoing clinical trials and recent index inclusions remain key near-term catalysts, the size of the reported quarterly loss raises questions around cash burn and the timeline to profitability. This new financial data could shift expectations for the pace of hiring, R&D investment, or the need for additional funding, potentially affecting sentiment around CRISPR's risk profile. On balance, the recent news does not appear to instantly derail the main product development catalysts investors were tracking, but it sharpens focus on the sustainability of current spending levels and paths to revenue growth in a high-cost environment. But with losses widening, funding needs are something every investor should watch closely. CRISPR Therapeutics' shares have been on the rise but are still potentially undervalued. Find out how large the opportunity might be. Exploring Other Perspectives Eighteen members of the Simply Wall St Community offer fair value estimates for CRISPR Therapeutics, ranging from US$14.57 to US$150.97 per share. As these forecasts reveal, opinions differ widely on the company's trajectory, particularly given growing expenses flagged in the latest earnings. Exploring several alternative viewpoints can help you understand the breadth of market expectations. Explore 18 other fair value estimates on CRISPR Therapeutics - why the stock might be worth less than half the current price! Build Your Own CRISPR Therapeutics Narrative Disagree with this assessment? Create your own narrative in under 3 minutes - extraordinary investment returns rarely come from following the herd. A great starting point for your CRISPR Therapeutics research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision. Our free CRISPR Therapeutics research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate CRISPR Therapeutics' overall financial health at a glance. Ready For A Different Approach? Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped: Find companies with promising cash flow potential yet trading below their fair value. Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit. These 14 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include CRSP. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

These 2 FTSE stocks could benefit from the growth of AI and the demand for new data centres
These 2 FTSE stocks could benefit from the growth of AI and the demand for new data centres

Yahoo

timean hour ago

  • Yahoo

These 2 FTSE stocks could benefit from the growth of AI and the demand for new data centres

In my opinion, there are two FTSE stocks — Segro (LSE:SGRO) and Tritax Big Box REIT (LSE:BBOX) — that look set to gain from the anticipated explosion in the demand for data centres. According to McKinsey & Company, by 2030, $7trn will need to be spent globally on building the physical infrastructure necessary to house the servers and other hardware required to run artificial intelligence (AI) applications. Closer to home, Barbour ABI has found nearly 100 live UK planning applications for such properties. And reflecting their energy intensity, Mordor Intelligence reckons the capacity of domestic data centres will grow from 2,590 MW in 2025 to 4,750 MW by 2030. That's equivalent to an average annual increase of 12.9%. The country's number one As the UK's largest real estate investment trust (REIT), Segro already has a significant foothold in the market. It owns Slough Trading Estate, Europe's largest business park and home to the continent's biggest cluster of data centres. It also leases other warehouses to companies operating in the sector. Its tenants include Equinix and Digital Realty Trust, two of the industry's largest players. But its share price has disappointed recently — it's down 28% since August 2024. And the commercial property market can be volatile. However, its balance sheet is strong — its loan-to-value was 31% at 30 June. Also, 73% of its lettable area is located in seven countries in continental Europe, which provides it with a certain degree of diversification. Another option Tritax Big Box REIT, the UK's largest owner of logistics facilities, now has two data centres in its portfolio and has announced plans to build a new one near Heathrow airport. It anticipates spending £200m on similar properties in 2025 and £100m-£200m annually thereafter. It estimates the annual rental yield will be 9%-11%. Not surprisingly, the trust views the sector as one of its key growth drivers. As part of its expansion plans, Tritax has made an offer to buy Warehouse REIT. If the deal is successful, it will create a combined £7.4bn property portfolio. The takeover target has 409 tenants at 60 sites in England and Scotland. Immediate cost savings of £5.5m a year are expected. The proposed merger reflects a trend in the investment trust industry where stock market valuations are often lower than the value of the underlying assets. This apparent lack of appreciation from investors has frustrated directors and shareholders alike. Tritax presently trades at a 28% discount. Warehouse is valued at 11% less than its book value. Good for income One of the principal attractions of REITs is that to qualify for certain tax exemptions they must return at least 90% of rental profits to shareholders. This means they usually offer generous yields. For example, based on dividends paid over the past 12 months, Tritax is presently (15 August) offering a return of 5.6%. For comparison, Segro's is 4.6%. Please note that tax treatment depends on the individual circumstances of each client and may be subject to change in future. The content in this article is provided for information purposes only. It is not intended to be, neither does it constitute, any form of tax advice. However, the trust's dividend could come under pressure if interest rates remain at historically high levels. And possible vacancies remain an ever-present threat. But like Segro, I think Tritax has exposure to a sector that's going to see significant growth over the next decade or so. Those that agree with me could consider adding either of them to their portfolios. The post These 2 FTSE stocks could benefit from the growth of AI and the demand for new data centres appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool James Beard has no position in any of the shares mentioned. The Motley Fool UK has recommended Segro Plc, Tritax Big Box REIT Plc, and Warehouse REIT Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025

2 top AI-related stocks for investors to consider buying!
2 top AI-related stocks for investors to consider buying!

Yahoo

time3 hours ago

  • Yahoo

2 top AI-related stocks for investors to consider buying!

Companies linked to artificial intelligence (AI) have become highly coveted stocks to buy. We're mainly talking about US tech shares like Nvidia, whose semiconductors power advanced AI models, and businesses like Microsoft, Meta, and Alphabet that are integrating AI into their existing operations. Many investors worry that these AI shares now command sky-high valuations. They fear this leaves them at risk of price corrections if the stocks' momentum slows. But investors don't need to buy these pricey US stocks to target large returns from the AI boom. Here are two UK shares to consider for the new tech revolution. Riding the data centre boom Sophisticated AI models require thousands of chips working in tandem, meaning small server rooms just don't cut it anymore. This is driving demand for industrial-sized data centres with sophisticated cooling systems and robust power infrastructure. This provides an enormous opportunity for warehouse operators like Tritax Big Box (LSE:BBOX). Accordingly, the FTSE 250 real estate investment trust (or REIT) — which chiefly rents it large-scale spaces out to delivery companies, retailers, and fast-moving consumer goods (FCMG) companies — is pushing aggressively into data centres. The company acquired its first data hub site in January, which it predicts will be 'one of the largest data centres in the UK'. And it followed this with a second shortly afterwards. The sites — which have a combined potential capacity of 272 MW — are in well-connected locations in London and have scope for long-term expansion. With a pipeline of another 1 GW, Tritax is positioning itself as a major player in the digital infrastructure boom. The UK currently has 477 data centres in operation. And construction firm Barbor ABI believes almost another 100 new sites will be needed between now and 2030 to meet demand. This provides a wonderful growth opportunity for the likes of Tritax. Be mindful, though, that data centre development carries risks. Like its logistics and storage hubs, returns are at the mercy of rising build costs and interest rates. Please note that tax treatment depends on the individual circumstances of each client and may be subject to change in future. The content in this article is provided for information purposes only. It is not intended to be, neither does it constitute, any form of tax advice. Another top AI-related stock Cable maker Volex (LSE:VLX) is another great data centre play to consider. The high-speed cables it manufactures are essential tools in ensuring a reliable and fast-moving data connection. More specifically, the company is a pioneer in the direct attach cables (DACs) segment. These are especially critical for AI applications, as they facilitate high bandwidth with minimal latency. And they are helping to drive business with both new and existing customers. Volex sells its cables across the world, leaving it exposed to trade tariff-related pressures. But these troubles haven't yet derailed its ability to deliver strong revenues growth — organic sales leapt 10.4% at constant currencies between April and June. The business said its latest sales numbers reflect 'continued momentum in the Electric Vehicles and Complex Industrial Technology end-markets, notably among Data Centre customers'. As well as data centres, Volex has exposure to multiple other growth areas like electric cars, renewable energy, healthcare, and automation. This provides added profit-making opportunities, while simultaneously broadening its sales base and reducing reliance on any single market to drive earnings. I think it's a great all-rounder to consider for the booming digital economy. The post 2 top AI-related stocks for investors to consider buying! appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended Alphabet, Meta Platforms, Microsoft, Nvidia, and Tritax Big Box REIT Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025 Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store